Why does an injectable version of Superdrol exist?

The injectable format addresses oral Superdrol's primary limitation - first-pass hepatotoxicity. When swallowed, oral Superdrol passes through the liver at concentrated doses during first-pass metabolism, driving severe enzyme elevation. Injected intramuscularly, Methyldrostanolone enters the bloodstream directly, reaching the liver only at systemic blood concentrations rather than the concentrated first-pass dose. The result is meaningfully reduced hepatic enzyme elevation at equivalent effective doses.

Is injectable Superdrol completely safe for the liver?

No - hepatotoxicity is reduced but not eliminated. The compound still reaches the liver via systemic circulation. Liver enzyme monitoring is still essential during injectable Superdrol cycles. The injectable format reduces first-pass hepatic exposure - it does not remove hepatic risk entirely. Cycle length is limited to 4-6 weeks (slightly longer than oral's 3-4 week maximum due to the reduced first-pass load).

Can injectable Superdrol be combined with oral Superdrol for a stronger effect?

No - this would negate the hepatotoxicity reduction that is the primary reason for using the injectable format. Combining injectable and oral forms doubles the total Methyldrostanolone dose and recreates the combined oral first-pass plus systemic hepatic burden that the injectable format was designed to avoid.

How does the dosing differ between oral and injectable Superdrol?

At 40mg/ml, common daily injectable doses are 20-40mg/day (0.5-1ml). The comparable oral dose would be 20-40mg/day (2-4 tablets). The anabolic effect per milligram is similar - the difference is hepatic exposure, not pharmacological potency at the androgen receptor.

Does the injectable format change Superdrol's other side effects?

The route change does not alter the compound's inherent pharmacological properties - lethargy, blood pressure elevation, HPG suppression and the absence of aromatisation are all the same regardless of whether Superdrol is taken orally or injected. Only the first-pass hepatotoxicity is meaningfully changed by switching to the injectable format.

Does injectable Superdrol build muscle?

Methasterone has potent anabolic activity and is marketed for increasing muscle mass and strength. However, there is no established medically safe bodybuilding regimen.

Superdrol Inj - Injectable Methyldrostanolone 40mg/ml

Name: Superdrol Inj by Dragon Pharma
Brand: Dragon Pharma
SKU: OFFER-3883
Price: 95.0 USD
Availability: OutOfStock

Superdrol Injectable - Methyldrostanolone 40mg/ml by Dragon Pharma

Superdrol Injectable is Dragon Pharma's injectable formulation of Methyldrostanolone at 40mg/ml in MCT oil - the same active compound as Superdrol 10mg tablets, administered via intramuscular injection to bypass the first-pass hepatic metabolism that drives oral Superdrol's severe hepatotoxicity. For the complete compound background - including the methylated Masteron structure, prohormone history and mechanism - see the oral Superdrol page.

Also searched as: Injectable Superdrol, Methyldrostanolone injection, Superdrol Inj Dragon Pharma, injectable methasterone.

Why Injectable - The Hepatotoxicity Reduction Rationale

Injectable Methyldrostanolone is unusual - 17-alpha-alkylated compounds are almost exclusively oral because the alkylation's primary purpose is oral bioavailability. The injectable format addresses the oral form's core limitation:

When oral Superdrol is swallowed, 100% of the absorbed dose passes through the liver (first-pass metabolism) before reaching systemic circulation. The 17-alpha-methyl group protects the compound from hepatic breakdown - but this resistance also means the compound is fully present in liver tissue at high concentration during this first pass, driving the severe hepatotoxicity
When Superdrol is injected intramuscularly, it enters the bloodstream directly - bypassing the first-pass hepatic exposure entirely. The compound still reaches the liver via systemic circulation, but at the systemic blood concentration rather than the concentrated first-pass dose
The result: injectable Methyldrostanolone produces significantly lower liver enzyme elevation than the oral form at equivalent doses - though hepatotoxicity is not eliminated (the compound still passes through the liver systemically) - it is meaningfully reduced
This reduction in first-pass hepatic load is the primary reason for the injectable format's existence - it allows Superdrol's anabolic effects to be used with a more manageable hepatic safety profile

Oral vs Injectable Superdrol - The Practical Comparison

Parameter	Superdrol Injectable (40mg/ml)	Superdrol Oral (10mg/tab)
Route	Intramuscular injection	Oral tablet
First-pass hepatic exposure	Bypassed - systemic delivery only	100% first-pass through liver
Hepatotoxicity	Reduced - still present systemically	Severe - first-pass concentration
Bioavailability	Near-complete via IM	Moderate - first-pass metabolism
Convenience	Injection required	Oral tablet - most convenient
Dose precision	Volume-based - flexible	Tablet-based - 10mg increments
Same anabolic compound	Yes - identical active molecule	Yes

Dosage and Administration

Protocol	Dose	Frequency	Duration
Standard performance	20-40 mg/day	Daily IM injection	4-6 weeks maximum
Conservative start	20 mg/day (0.5ml)	Daily	Assess hepatic response before escalating

At 40mg/ml, a 0.5ml daily injection delivers 20mg; a 1ml injection delivers 40mg. The IM injection route is typically gluteal, vastus lateralis or deltoid - rotating sites daily. Because hepatotoxicity is reduced but not eliminated, cycle length is still strictly limited to 4-6 weeks, which is somewhat longer than the 3-4 week oral cycle maximum due to the reduced first-pass load. Liver enzyme monitoring remains essential throughout.

Side Effects

Hepatotoxicity - reduced versus oral form but present; liver enzyme monitoring remains essential throughout any injectable Superdrol cycle
Lethargy - same pronounced fatigue as oral Superdrol; inherent to the compound regardless of route
No aromatisation - no estrogenic side effects from the compound itself
Suppression of natural testosterone - Post Cycle Therapy required
Blood pressure elevation - common; monitor throughout
Injection site discomfort - daily IM injection requires site rotation

Protocol Context

Enantat 250 or other testosterone base - injectable Superdrol is added as a mass/strength compound to a testosterone foundation
Never combine with oral 17-AA compounds - injectable route reduces but does not eliminate hepatic burden; stacking with oral AAS negates the hepatotoxicity advantage
Clomid or Nolvadex for PCT

"Injectable Superdrol bypasses the first-pass hepatic concentration that makes the oral form so liver-toxic - delivering Methyldrostanolone's exceptional anabolic effect with a meaningfully reduced hepatic burden compared to swallowing the same dose as a tablet."

Storage and Handling

Store Superdrol Injectable at room temperature away from direct sunlight and heat. Use sterile technique for every draw - fresh needle for drawing, separate needle for injection.